152 related articles for article (PubMed ID: 36047374)
1. Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.
Cho WK; Kim HS; Park W; Chang CS; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG
J Gynecol Oncol; 2022 Nov; 33(6):e71. PubMed ID: 36047374
[TBL] [Abstract][Full Text] [Related]
2. The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
Cho WK; Kim HS; Park W; Kim YS; Kang J; Kim YB; Kim YS; Kim YJ; Kim KR; Kim JH; Kwon SY; Choi JH; Yoon M; Kim NI
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):154-163. PubMed ID: 36935025
[TBL] [Abstract][Full Text] [Related]
3. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of cytology and high-risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions.
Ye L; Gan M; Yao Y; Lu B
Cancer Cytopathol; 2024 Feb; ():. PubMed ID: 38373111
[TBL] [Abstract][Full Text] [Related]
5. International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.
Ren H; Almadani N; Pors J; Leung S; Ho J; Chow C; Ta M; Park KJ; Stolnicu S; Soslow R; Huntsman D; Gilks BC; Hoang L
Int J Gynecol Pathol; 2021 Nov; 40(6):533-540. PubMed ID: 34612210
[TBL] [Abstract][Full Text] [Related]
6. Prognosis determination of endocervical adenocarcinomas morphologically reclassified as HPV associated or HPV independent.
Carvalho CF; Costa LBE; Sanches NC; Damas II; Andrade LALA; Vale DB
Int J Gynaecol Obstet; 2023 Mar; 160(3):993-1000. PubMed ID: 36074054
[TBL] [Abstract][Full Text] [Related]
7. Endocervical Adenocarcinoma: Comprehensive Histological Review and Re-classification of 123 Consecutive Cases According to the Updated World Health Organization Classification of Female Genital Tumors.
Lee Y; Bae H; Kim HS
Anticancer Res; 2022 Sep; 42(9):4627-4639. PubMed ID: 36039458
[TBL] [Abstract][Full Text] [Related]
8. Programmed death-ligand 1 expression in human papillomavirus-independent cervical adenocarcinoma and its prognostic significance.
Chen L; Lucas E; Zhang X; Liu Q; Zhuang Y; Lin W; Chen H; Zhou F
Histopathology; 2022 Jan; 80(2):338-347. PubMed ID: 34455625
[TBL] [Abstract][Full Text] [Related]
9. Poor Treatment Outcomes of Locally Advanced Cervical Adenocarcinoma of Human Papilloma Virus Independent Type, Represented by Gastric Type Adenocarcinoma: A Multi-Center Retrospective Study (Sankai Gynecology Study Group).
Seki T; Kojima A; Okame S; Yamaguchi S; Okamoto A; Tokunaga H; Nishio S; Takei Y; Yokoyama Y; Yoshida M; Teramoto N; Mikami Y; Shimada M; Kigawa J; Takehara K
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980616
[TBL] [Abstract][Full Text] [Related]
10. Concordance Between Biopsy and Resection Diagnoses of Uterine Cervical Adenocarcinoma According to the Updated World Health Organization 2020 Classification: A Multi-Institutional Study Elucidating Real-World Practice in Japan.
Kawakami F; Yanai H; Teramoto N; Miyama Y; Yasuda M; Minamiguchi S; Iwamoto M; Kiyokawa T; Mikami Y
Arch Pathol Lab Med; 2024 Jan; ():. PubMed ID: 38282572
[TBL] [Abstract][Full Text] [Related]
11. Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions.
Stolnicu S; Allison D; Patrichi A; Flynn J; Iasonos A; Soslow RA
Adv Anat Pathol; 2024 Jan; 31(1):1-14. PubMed ID: 37638549
[TBL] [Abstract][Full Text] [Related]
12. Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).
Stolnicu S; Hoang L; Chiu D; Hanko-Bauer O; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Soslow RA
Am J Surg Pathol; 2019 Apr; 43(4):466-474. PubMed ID: 30720532
[TBL] [Abstract][Full Text] [Related]
13. Incidence and Clinicopathologic Characteristics of Human Papillomavirus-independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases.
Stolnicu S; Allison D; Praiss AM; Tessier-Cloutier B; Momeni Boroujeni A; Flynn J; Iasonos A; Serrette R; Hoang L; Patrichi A; Terinte C; Pesci A; Mateoiu C; Lastra RR; Kiyokawa T; Ali-Fehmi R; Kheil M; Oliva E; Devins KM; Abu-Rustum NR; Soslow RA
Am J Surg Pathol; 2023 Dec; 47(12):1376-1389. PubMed ID: 37702216
[TBL] [Abstract][Full Text] [Related]
14. [Endocervical adenocarcinomas classified by International Endocervical Adenocarcinoma Criteria and Classification: a clinicopathological and prognostic analysis of 286 cases].
Lyu BJ; Shi HY; Shao Y; Liu Q; Lyu WG
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1014-1019. PubMed ID: 34496491
[No Abstract] [Full Text] [Related]
15. Transforming acidic coiled-coil protein-3: a novel marker for differential diagnosis and prognosis prediction in endocervical adenocarcinoma.
Wen YL; Yan SM; Wei W; Yang X; Zhang SW; Yun JP; Liu LL; Luo RZ
Mol Med; 2021 Jun; 27(1):60. PubMed ID: 34134633
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological features and outcomes in gastric-type of HPV-independent endocervical adenocarcinomas.
Chen L; Niu Y; Wan X; Yu L; Zhang X; Strickland AL; Dong L; Zhou F; Lu W
BMC Cancer; 2021 Oct; 21(1):1095. PubMed ID: 34635081
[TBL] [Abstract][Full Text] [Related]
17. Endocervical neoplasia: Pathologic updates in diagnosis and prognosis.
Rivera-Colón G; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):213-227. PubMed ID: 34953647
[TBL] [Abstract][Full Text] [Related]
18. Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
Stolnicu S; Barsan I; Hoang L; Patel P; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Abu-Rustum NR; Pike MC; Soslow RA
Gynecol Oncol; 2018 Jul; 150(1):56-60. PubMed ID: 29859673
[TBL] [Abstract][Full Text] [Related]
19. Single-Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus-Associated (HPVA) and Non-HPVA Adenocarcinoma.
Qiu J; Qu X; Wang Y; Guo C; Lv B; Jiang Q; Su W; Wang L; Hua K
Adv Sci (Weinh); 2023 Apr; 10(10):e2204951. PubMed ID: 36725337
[TBL] [Abstract][Full Text] [Related]
20. Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
Neil AJ; Li YY; Hakam A; Nucci MR; Parra-Herran C
Histopathology; 2024 Jan; 84(2):369-380. PubMed ID: 37920148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
